Matches in Wikidata for { <http://www.wikidata.org/entity/Q100753339> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q100753339 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 21ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q100753339 description "article scientifique publié en 2020" @default.
- Q100753339 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100753339 description "scientific article published on 21 October 2020" @default.
- Q100753339 description "wetenschappelijk artikel" @default.
- Q100753339 description "наукова стаття, опублікована 21 жовтня 2020" @default.
- Q100753339 name "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 name "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 name "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 type Item @default.
- Q100753339 label "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 label "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 label "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 prefLabel "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 prefLabel "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 prefLabel "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 P1433 Q100753339-5D46D320-8523-4AAA-888D-DCA89E52363C @default.
- Q100753339 P1476 Q100753339-C5D97AB4-B3D4-484C-8482-39E4BB4FC97A @default.
- Q100753339 P2093 Q100753339-08E0595D-483B-4E60-B5AA-AF0BBE79B02E @default.
- Q100753339 P2093 Q100753339-0D214B32-413B-4F73-B4C5-858360425623 @default.
- Q100753339 P2093 Q100753339-0EDD9036-FF0E-4A21-9727-3ED68DDB07FF @default.
- Q100753339 P2093 Q100753339-2591E29B-4514-4DE8-A379-0E3C3D8EBD4A @default.
- Q100753339 P2093 Q100753339-752F65D0-4B37-47A1-ABEF-EA4A9C577704 @default.
- Q100753339 P2093 Q100753339-8F297A3F-93D1-465B-80CC-788D25ED5067 @default.
- Q100753339 P2093 Q100753339-A416B881-9721-4980-A732-5D66B20662E1 @default.
- Q100753339 P2093 Q100753339-D41F6A69-68AC-42CE-8A9A-04A1FB245FA6 @default.
- Q100753339 P31 Q100753339-A052D3EF-6732-4EBA-8609-CCBA3C2777A5 @default.
- Q100753339 P356 Q100753339-5927543F-40B3-4CB1-A1AB-30A4BB81C763 @default.
- Q100753339 P50 Q100753339-0CC2A2FC-8B1C-44F6-BE9F-BB1B10B9D5CF @default.
- Q100753339 P50 Q100753339-45D8B6DE-3BDA-4ED3-A628-BEBBAC2C39D5 @default.
- Q100753339 P50 Q100753339-BD24CF90-4CAC-42CC-A6D3-30D52FEEE466 @default.
- Q100753339 P577 Q100753339-648AB9BE-4AA5-44EC-98BC-7B75BD0BD95E @default.
- Q100753339 P698 Q100753339-561309E5-64B8-433F-9324-CAFE451973D0 @default.
- Q100753339 P921 Q100753339-4DA0EBCC-9342-47AF-83D7-8BD4E0923BFA @default.
- Q100753339 P356 DKAA396 @default.
- Q100753339 P698 33083833 @default.
- Q100753339 P1433 Q6294770 @default.
- Q100753339 P1476 "Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections" @default.
- Q100753339 P2093 "Alejandro Beceiro" @default.
- Q100753339 P2093 "Antonio Oliver" @default.
- Q100753339 P2093 "Bruno-Kotska Rodiño-Janeiro" @default.
- Q100753339 P2093 "Gabriel Cabot" @default.
- Q100753339 P2093 "Germán Bou" @default.
- Q100753339 P2093 "Jorge Arca-Suárez" @default.
- Q100753339 P2093 "Juan Carlos Vázquez-Ucha" @default.
- Q100753339 P2093 "Manuel Rodríguez-Iglesias" @default.
- Q100753339 P31 Q13442814 @default.
- Q100753339 P356 "10.1093/JAC/DKAA396" @default.
- Q100753339 P50 Q42844659 @default.
- Q100753339 P50 Q46865144 @default.
- Q100753339 P50 Q96682008 @default.
- Q100753339 P577 "2020-10-21T00:00:00Z" @default.
- Q100753339 P698 "33083833" @default.
- Q100753339 P921 Q31856 @default.